deferoxamine has been researched along with glycine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bulman, RA; Griffin, RJ; Russell, AT | 1 |
| Roeser, NF; Sogabe, K; Venkatachalam, MA; Weinberg, JM | 1 |
| Boehme, P; Gordeuk, VR; John, C; Loyevsky, M; Sacci, JB; Weglicki, W | 1 |
| Abels, C; Botzlar, A; Goetz, AE; Langer, S; Pahernik, S; Rick, K; Szeimies, RM | 1 |
| Ferguson, T; Hilliard, G; Millhorn, DE; Yuan, Y | 1 |
| Caro, J; Minchenko, O; Opentanova, I | 1 |
| Bartrons, R; Caro, J; Duran, J; Gómez, M; Kong, X; Navarro-Sabaté, A; Obach, M; Perales, JC; Rosa, JL; Ventura, F | 1 |
| Esumi, H; Minchenko, D; Minchenko, O; Ogura, T; Opentanova, I | 1 |
| Dendorfer, A; Dominiak, P; Heidbreder, M; Hellwig-Bürgel, T; Jöhren, O; Qadri, F | 1 |
| Bogdanovic, N; Karelson, E; Land, T; Reis, K; Zharkovsky, A | 1 |
| de Groot, H; Rauen, U; Wille, T | 1 |
| Altobelli, A; Belanger, AJ; Cheng, SH; Jiang, C; Leger, AJ; Mosquea, LM; Song, A; Yew, NS | 1 |
| Sonier, MB; Weger, HG | 1 |
| Dold, S; Hülser, M; Kollmar, O; Menger, MD; Moussavian, MR; Scheuer, C; Schilling, MK; Seibert, K; von Heesen, M; Wagner, M | 1 |
| Ferreira, GC; Fratz, EJ; Hunter, GA | 1 |
| Agis, H; Fügl, A; Gruber, R; Keibl, C; Kuchler, U; Schwarze, UY; Tangl, S | 1 |
| Bastiaansen, KC; Bitter, W; Llamas, MA; van Ulsen, P; Wijtmans, M | 1 |
| Bouchecareilh, M; Hutt, DM; Marchal, C; Roth, DM | 1 |
| Agis, H; Janjić, K; Lilaj, B; Moritz, A | 1 |
| Cordes, BA; Iempridee, T; Kraus, RJ; Lambert, PF; Lee, DL; Mertz, JE; Patel, P; Sathiamoorthi, S; Yu, X; Yuan, X | 1 |
21 other study(ies) available for deferoxamine and glycine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An examination of some complexing agents for ability to remove intracellularly deposited plutonium.
Topics: Animals; Bone and Bones; Bufexamac; Chelating Agents; Chromones; Cricetinae; Deferoxamine; Female; Glycine; Hydroxamic Acids; Liver; Mesocricetus; Pentetic Acid; Piperazines; Plutonium; Pyridines | 1979 |
Differential cytoprotection by glycine against oxidant damage to proximal tubule cells.
Topics: Animals; Antioxidants; Cell Hypoxia; Cells, Cultured; Deferoxamine; Female; Glycine; Hemostatics; Hydroxyquinolines; Iron; Kidney Tubules, Proximal; Lipid Peroxidation; Oxidative Stress; Peroxides; Phenylenediamines; Rabbits; Reactive Oxygen Species; Siderophores; tert-Butylhydroperoxide; Vitamin K | 1996 |
Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Deferoxamine; Erythrocytes; Ethylenediamines; Ferrous Compounds; Fluoresceins; Fluorescent Dyes; Glycine; Humans; Iron Chelating Agents; Liver; Malaria, Falciparum; Mice; Microscopy, Fluorescence; Parasitemia; Plasmodium falciparum; Plasmodium yoelii; Prodrugs; Quaternary Ammonium Compounds; Razoxane; Spectrometry, Fluorescence; Surface Properties | 1999 |
Active and higher intracellular uptake of 5-aminolevulinic acid in tumors may be inhibited by glycine.
Topics: Aminolevulinic Acid; Animals; Biological Transport; Cricetinae; Deferoxamine; Diffusion Chambers, Culture; Glycine; Male; Melanoma, Amelanotic; Mesocricetus; Neoplasm Transplantation; Phenanthrolines; Protoporphyrins; Skin Neoplasms; Spectrometry, Fluorescence | 1999 |
Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.
Topics: Amino Acid Sequence; Animals; Basic Helix-Loop-Helix Transcription Factors; CHO Cells; Cobalt; Cricetinae; Deferoxamine; Glycine; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Ligases; Molecular Sequence Data; Rats; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2003 |
Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; DNA-Binding Proteins; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycine; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; Mice; Mice, Inbred C57BL; Nuclear Proteins; Organ Specificity; Phosphofructokinase-2; Protein Biosynthesis; Proteins; Rats; RNA, Messenger; Transcription Factors | 2003 |
6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.
Topics: Animals; Binding Sites; Biotinylation; Blotting, Western; Cell Hypoxia; Cell Line; Cell Proliferation; Cobalt; Deferoxamine; Enhancer Elements, Genetic; Fructosediphosphates; Gene Deletion; Gene Expression Regulation; Genes, Reporter; Glycine; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Luciferases; Mice; Models, Genetic; Oligonucleotides; Oxygen; Phosphofructokinase-2; Plasmids; Promoter Regions, Genetic; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Software; Time Factors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Up-Regulation | 2004 |
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycine; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; Male; Phosphofructokinase-2; Prostatic Neoplasms; RNA, Messenger; Transcription Factors; Transcription, Genetic; Transcriptional Activation | 2004 |
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals.
Topics: Aldehyde Reductase; Alkaloids; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Benzophenanthridines; Deferoxamine; DNA-Binding Proteins; Glucose Transporter Type 4; Glycine; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemic Preconditioning, Myocardial; Male; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Phenanthridines; Protein Kinase C; Rats; Rats, Wistar; Receptors, Aryl Hydrocarbon; Sulfhydryl Compounds; Superoxides; Trans-Activators; Transcription Factors | 2005 |
Critical role of methionine-722 in the stimulation of human brain G-proteins and neurotoxicity induced by London familial Alzheimer's disease (FAD) mutated V717G-APP(714-723).
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Case-Control Studies; Cell Differentiation; Cells, Cultured; Deferoxamine; Dose-Response Relationship, Drug; Estradiol; Female; Glutathione; Glycine; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Melatonin; Methionine; Middle Aged; Peptides; Protein Binding; Rats; Temporal Lobe; Valine | 2007 |
Improvement of the cold storage of blood vessels with a vascular preservation solution. Study in porcine aortic segments.
Topics: Adenosine; Alanine; Allopurinol; Animals; Aorta; Aspartic Acid; Buffers; Cell Survival; Citrates; Cold Temperature; Deferoxamine; Endothelial Cells; Glucose; Glutathione; Glycine; Histidine; Hydrogen-Ion Concentration; Insulin; Iron; Iron Chelating Agents; Mannitol; Membrane Potential, Mitochondrial; Mitochondria; Organ Preservation; Organ Preservation Solutions; Platelet Adhesiveness; Potassium Chloride; Procaine; Raffinose; Rewarming; Swine; Time Factors | 2008 |
Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine.
Topics: Animals; Cell Differentiation; Cell Line; Deferoxamine; Female; Gene Expression Regulation; Glycine; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophage Colony-Stimulating Factor; Mice; Mitogen-Activated Protein Kinases; Osteoclasts; Procollagen-Proline Dioxygenase; RANK Ligand; Rats; Rats, Sprague-Dawley; Siderophores; Vascular Endothelial Growth Factor A | 2010 |
Plasma membrane ferric reductase activity of iron-limited algal cells is inhibited by ferric chelators.
Topics: Cell Membrane; Chlorella; Deferoxamine; FMN Reductase; Glycine; Glyphosate; Hydroxamic Acids; Iron; Iron Chelating Agents; Siderophores | 2010 |
Split-liver procedure and inflammatory response: improvement by pharmacological preconditioning.
Topics: Animals; Apoptosis; Cell Movement; Cytokines; Deferoxamine; Drug Therapy, Combination; Female; Glycine; Graft Survival; Inflammation; Leukocytes; Liver Transplantation; Male; Models, Animal; Pentoxifylline; Preoperative Care; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2011 |
Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.
Topics: 5-Aminolevulinate Synthetase; Animals; Cell Death; Cell Membrane; Culture Media; Deferoxamine; Glycine; Green Fluorescent Proteins; HeLa Cells; Humans; K562 Cells; Light; Mice; Mutant Proteins; Paclitaxel; Plasmids; Protoporphyrins; Transfection | 2014 |
Dimethyloxalylglycine lyophilized onto bone substitutes increase vessel area in rat calvarial defects.
Topics: Angiogenesis Inducing Agents; Animals; Bone Regeneration; Bone Substitutes; Deferoxamine; Diabetes Mellitus, Experimental; Glycine; Male; Neovascularization, Physiologic; Rats; Rats, Wistar; Skull | 2015 |
Self-cleavage of the Pseudomonas aeruginosa Cell-surface Signaling Anti-sigma Factor FoxR Occurs through an N-O Acyl Rearrangement.
Topics: Bacterial Outer Membrane Proteins; Catalytic Domain; Cell Membrane; Deferoxamine; DNA Mutational Analysis; Escherichia coli; Ferric Compounds; Gene Expression Regulation, Bacterial; Glycine; Hydrolysis; Periplasm; Plasmids; Protein Processing, Post-Translational; Pseudomonas aeruginosa; Receptors, Cell Surface; Siderophores; Sigma Factor; Signal Transduction; Threonine | 2015 |
Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Topics: Acetylation; Blotting, Western; Cell Line, Tumor; Chromatin; Chromosomal Proteins, Non-Histone; Cyclin D1; Deferoxamine; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; Glycine; Hepatocytes; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Protein Biosynthesis; Protein Processing, Post-Translational; RNA, Small Interfering; Vorinostat | 2017 |
Formation of spheroids by dental pulp cells in the presence of hypoxia and hypoxia mimetic agents.
Topics: Chemokine CXCL12; Deferoxamine; Dental Pulp; Enzyme-Linked Immunosorbent Assay; Glycine; Humans; Hypoxia; Interleukin-8; Mimosine; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2018 |
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
Topics: Cell Line, Tumor; Cyclopentanes; Deferoxamine; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Glycine; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Iron Chelating Agents; Isoquinolines; Lymphocytes; Morpholines; Piperazines; Prolyl-Hydroxylase Inhibitors; Promoter Regions, Genetic; Protein Binding; Pyrimidines; Pyrones; Response Elements; RNA, Small Interfering; Signal Transduction; Trans-Activators; Tumor Suppressor Protein p53; Virus Activation | 2020 |